SCHEMBL21332628

SCHEMBL21332628

FC(F)(F)c1ccc(C#CBr)cc1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 6/20 0.48
▸ ALDH1A1 P00352 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ CES2 O00748 1/20 0.38
▸ CES1 P23141 1/20 0.38
▸ ORAI1 Q96D31 1/20 0.38
▸ ORAI2 Q96SN7 1/20 0.38
▸ ORAI3 Q9BRQ5 1/20 0.38
▸ TRPV6 Q9H1D0 1/20 0.38
▸ MGLL Q99685 1/20 0.38
▸ GSK3B P49841 2/20 0.36
▸ PTPN1 P18031 2/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ TAAR1 Q96RJ0 1/20 0.35
▸ PTPN6 P29350 1/20 0.35
▸ PTPN11 Q06124 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14998069 0.85 KIF11 (0.56) KIF11ALDH1A1TSHRCES2CES1
SCHEMBL16747679 0.85 KIF11 (0.56) KIF11ALDH1A1TSHRCES2CES1
SCHEMBL7699654 0.80 KIF11 (0.52) KIF11ALDH1A1TSHRCES2CES1
SCHEMBL8617788 0.79 KIF11 (0.47) KIF11ALDH1A1TSHRCES2CES1
SCHEMBL2533168 0.79 APP (0.42) CYP1A2
SCHEMBL29144381 0.76 KIF11 (0.48) KIF11ALDH1A1TSHRCES2CES1
SCHEMBL3827578 0.76 KIF11 (0.48) KIF11ALDH1A1TSHRCES2CES1
SCHEMBL28409237 0.76 KIF11 (0.48) KIF11ALDH1A1TSHRCES2CES1
SCHEMBL21332570 0.76 RARB (0.52) KIF11ALDH1A1TSHRCYP1A2
SCHEMBL5539093 0.76 KIF11 (0.48) KIF11ALDH1A1TSHRCES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115197046-B Halogenation method of unsaturated hydrocarbon 华南理工大学 2023-12-15 — — CN disclosed
CN-115197046-A Halogenation method of unsaturated hydrocarbon 华南理工大学 2022-10-18 — — CN disclosed
CN-110683971-B Method for synthesizing aryl acetylene alkyl sulfone compounds based on Hantzsch esters 台州学院 2021-09-10 — — CN disclosed
CN-110698369-B Method for synthesizing aryl acetylene alkyl sulfone compound based on alkyl fluoborate 台州学院 2021-08-24 — — CN disclosed
US-20210017110-A1 POLYCYCLIC AROMATIC COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME Board of Regents of the Nevada System Higher Education, on behalf of the University of Nevada, Reno (US) 2021-01-21 — — US disclosed
EP-3762363-A1 POLYCYCLIC AROMATIC COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME Board of Regents of the Nevada System of Higher Education, on Behalf of the University of Nevada, Reno (US) 2021-01-13 — — EP disclosed
CN-111819166-A Polycyclic aromatic compounds and methods of making and using the same 内华达高等教育系统董事会代表内华达大学雷诺分校 2020-10-23 — — CN disclosed
CN-110698369-A Method for synthesizing aryl acetylene alkyl sulfone compound based on alkyl fluoborate 台州学院 2020-01-17 — — CN disclosed
CN-110683971-A Method for synthesizing aryl acetylene alkyl sulfone compounds based on Hantzsch esters 台州学院 2020-01-14 — — CN disclosed
WO-2019173243-A1 POLYCYCLIC AROMATIC COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION, ON BEHALF OF THE UNIVERSITY OF NEVADA, RENO (US) 2019-09-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210017110-A1 POLYCYCLIC AROMATIC COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME AHR, PAH, ALKBH3 KIF11 4037/4885ALDH1A1 327/4885TSHR 4778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback